Connected With Latham
By Latham & Watkins
In each episode of Connected With Latham, we discuss ideas, developments, and trends shaping the global economy.
Latest episode
-
Episode 97 – Drug Pricing: How the Drug Pricing EO Impacts FDA and Overlaps with Grassley-Led Legislation
The “Lowering Drug Prices by Once Again Putting Americans First” addresses various FDA matters, such as importation from Canada and accelerated approval of generics and biosimilars. In this episode of Connected With Latham, Washington, D.C.... -
Episode 96 – The Growth Rocketship: Shield AI’s Takeoff Shows What’s Possible in Defensetech
Founded in 2015, uses technology and intelligence systems to protect service members and civilians. The venture-backed unicorn’s flagship autonomy software, Hivemind, powers aircraft, drones, and other platforms to reliably support complex missions.… -
Episode 95 – Drug Pricing: FDA in the Age of Executive Orders and DOGE
The initial months of the Trump administration have been marked by a flurry of executive orders and significant activity by the Department of Government Efficiency (DOGE). The US Food and Drug Administration is a key target of these efforts. In this.… -
Episode 94 – Drug Pricing: 2025 J.P. Morgan Healthcare Conference Takeaways and Outlook
Stakeholders from across the healthcare and biopharmaceutical industry recently convened in San Francisco for the annual J.P. Morgan Healthcare Conference. In this episode of Connected With Latham, Washington, D.C. partners and and associate ... -
Episode 93 – EU’s Digital Operational Resilience Act: What You Should Know and How to Stay Compliant
The deadline for the EU's Digital Operational Resilience Act (DORA) has arrived. This regulation applies to most financial entities operating in the EU market and impacts a broad range of third-party providers of technology-related services. In this.… -
Episode 92 – UK FinReg Focus Areas in 2025: Sectoral Trends
In this episode of Connected with Latham, the final of three episodes complementing Latham’s “10 Key Focus Areas for UK-Regulated Financial Services Firms in 2025” report, London partners and and counsel discuss the key cross-sector... -
Episode 91 – UK FinReg Focus Areas in 2025: Retail Markets
In this episode of Connected with Latham, the second of three episodes complementing Latham’s “10 Key Focus Areas for UK-Regulated Financial Services Firms in 2025” report, London partners and and counsel discuss the upcoming reform agenda... -
Episode 90 – UK FinReg Focus Areas in 2025: Wholesale Markets
In this episode of Connected with Latham, the first of three episodes complementing Latham’s “10 Key Focus Areas for UK-Regulated Financial Services Firms in 2025” report, London partners and and counsel discuss what will likely appear on the... -
Episode 89 – The Growth Rocketship: How BridgeBio’s Hub and Spoke Portfolio Strategy Set the Market for the Future of Biotech – Then, Now, and What’s Next?
In this episode of Connected With Latham, , Global Vice Chair of Latham’s Emerging Companies & Growth Practice, sits down with ’s Co-Founder and Chief Executive Officer Neil Kumar and Chief Financial Officer Brian Stephenson. Since 2015,... -
Episode 88 – Drug Pricing: How Might the Trump Administration Transform FDA Enforcement Activities?
FDA enforcement activities range from administrative actions like conducting establishment inspections and issuing warning letters to judicial enforcement through the Department of Justice, which can take the shape of civil or criminal actions. While…
